Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Rewalk Robotics Ltd

Healthcare US RWLK

NoneUSD
0.00(0%)

Last update at 2024-03-05T21:01:57.932808Z

Day Range

--
LowHigh

52 Week Range

0.560.89
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap44.73M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-19.04100M
  • Revenue TTM9.15M
  • Revenue Per Share TTM0.15
  • Gross Profit TTM 1.91M
  • Diluted EPS TTM-0.36

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -19.10200M -12.64200M -12.92500M -15.54400M -21.68000M
Minority interest - - - - -
Net income -19.56900M -12.73600M -12.97600M -15.55100M -21.67500M
Selling general administrative 7.13M 5.63M 4.98M 5.26M 6.79M
Selling and marketing expenses 9.84M 6.99M 5.75M 6.17M 7.90M
Gross profit 1.91M 2.90M 2.19M 2.73M 2.83M
Reconciled depreciation 0.20M 0.27M 0.28M 0.32M 0.46M
Ebit -19.30400M -12.92100M -12.28900M -14.04800M -19.67700M
Ebitda -19.10200M -12.65500M -12.00400M -13.75800M -19.21400M
Depreciation and amortization 0.20M 0.27M 0.28M 0.29M 0.46M
Non operating income net other - - - - -
Operating income -19.10200M -12.65500M -12.00400M -14.04800M -19.21400M
Other operating expenses 24.61M 18.62M 16.40M 18.92M 25.76M
Interest expense -0.20200M 0.28M 0.92M 1.50M 2.40M
Tax provision 0.47M 0.09M 0.05M 0.00700M -0.00500M
Interest income - - - 1.47M 2.44M
Net interest income -0.02200M 0.01M -0.93000M -1.53000M -2.42400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.47M 0.09M 0.05M 0.00700M -0.00500M
Total revenue 5.51M 5.97M 4.39M 4.87M 6.54M
Total operating expenses 21.01M 15.56M 14.19M 16.77M 22.04M
Cost of revenue 3.61M 3.06M 2.20M 2.15M 3.72M
Total other income expense net 0.02M 0.01M -0.92100M -1.49600M -0.04200M
Discontinued operations - - - - -
Net income from continuing ops -19.56900M -12.73600M -12.97600M -15.55100M -21.67500M
Net income applicable to common shares -19.56900M -12.73600M -12.97600M -15.55100M -21.67500M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 74.24M 94.75M 28.07M 24.37M 14.96M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.65M 0.61M 0.67M 0.34M 0.17M
Total liab 6.07M 5.37M 6.29M 13.59M 13.02M
Total stockholder equity 68.17M 89.38M 21.77M 10.78M 1.95M
Deferred long term liab - - - - -
Other current liab 1.97M 1.70M 1.30M 1.07M 1.09M
Common stock 4.49M 4.66M 1.83M 0.50M 0.19M
Capital stock 4.49M 4.66M 1.83M 0.50M 0.19M
Retained earnings -213.75000M -194.18100M -181.44500M -168.46900M -152.91800M
Other liab 0.96M 0.91M 0.70M 0.58M 0.67M
Good will - - - - -
Other assets 0.69M 1.06M 1.03M 1.06M 1.10M
Cash 67.90M 88.34M 20.35M 16.25M 9.55M
Cash and equivalents - - - - -
Total current liabilities 4.78M 4.04M 4.67M 10.17M 5.38M
Current deferred revenue 0.30M 0.32M 0.44M 0.32M 0.24M
Net debt -66.99900M -87.27800M -18.76700M -7.33600M -0.85900M
Short term debt 0.56M 0.64M 0.66M 6.08M 1.72M
Short long term debt - - - 5.44M 1.72M
Short long term debt total 0.90M 1.06M 1.58M 8.92M 8.69M
Other stockholder equity 277.43M 278.90M 201.39M 178.75M 157.22M
Property plant equipment 1.03M 1.17M 1.79M 2.24M 0.63M
Total current assets 72.51M 92.52M 25.25M 21.07M 13.24M
Long term investments - - - - -
Net tangible assets 68.17M 89.38M 21.77M 10.78M 1.95M
Short term investments - - - - -
Net receivables 1.04M 0.58M 0.68M 0.79M 0.76M
Long term debt - - - 1.53M 6.96M
Inventory 2.93M 2.99M 3.54M 3.12M 2.24M
Accounts payable 1.95M 1.38M 2.27M 2.70M 2.33M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -3.15700M -2.87200M -2.55100M
Additional paid in capital - - - - -
Common stock total equity - - 1.83M 0.50M 0.19M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.69M 1.06M 1.03M 1.06M 1.10M
Deferred long term asset charges - - - - -
Non current assets total 1.73M 2.23M 2.82M 3.30M 1.73M
Capital lease obligations 0.90M 1.06M 1.58M 1.95M -
Long term debt total - - - 1.53M 6.96M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.02500M -0.04700M -0.07300M -0.02200M -0.01300M
Change to liabilities 0.53M -0.81000M -0.24200M 0.55M 0.78M
Total cashflows from investing activities -0.02500M -0.04700M -0.07300M -0.02200M -0.01300M
Net borrowings - - -6.57300M -1.72200M -7.46600M
Total cash from financing activities -2.50000M 79.51M 16.72M 21.48M 9.71M
Change to operating activities 0.08M 0.48M 0.39M 0.07M 0.46M
Net income -19.56900M -12.73600M -12.97600M -15.55100M -21.67500M
Change in cash -20.49500M 68.00M 4.06M 6.64M -5.07600M
Begin period cash flow 89.05M 21.05M 16.99M 10.35M 15.42M
End period cash flow 68.56M 89.05M 21.05M 16.99M 10.35M
Total cash from operating activities -17.89100M -11.46900M -12.58900M -14.81500M -14.77400M
Issuance of capital stock 0.00000M 64.45M 19.07M 21.77M 13.58M
Depreciation 0.20M 0.27M 0.28M 0.32M 0.46M
Other cashflows from investing activities - -0.04700M -0.04700M -0.04700M -0.01300M
Dividends paid - - - - -
Change to inventory -0.11700M 0.43M -0.46900M -1.22100M 1.40M
Change to account receivables -0.40800M 0.10M 0.11M -0.03600M 0.32M
Sale purchase of stock -2.50000M - - 23.20M 13.58M
Other cashflows from financing activities -0.02500M 15.06M 4.62M 1.43M -0.01300M
Change to netincome 1.39M 1.27M 0.31M 1.05M 3.48M
Capital expenditures 0.03M 0.05M 0.07M 0.02M 0.01M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.09M 0.20M -0.21100M -0.63600M 2.96M
Stock based compensation 0.99M 0.83M 0.75M 1.11M 2.77M
Other non cash items 0.08M 1.07M -0.39200M -3.68600M 0.82M
Free cash flow -17.91600M -11.51600M -12.66200M -14.83700M -14.78700M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RWLK
Rewalk Robotics Ltd		 - -% - - - 4.43 0.78 1.06 -0.4516
ABT
Abbott Laboratories		 2.70 3.07% 90.53 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 5.31 1.74% 310.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 1.36 1.72% 80.63 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 1.27 2.86% 45.60 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Rewalk Robotics Ltd

3 Hatnufa Street, Yokneam Illit, Israel, 2069203

Key Executives

Name Title Year Born
Mr. Lawrence J. Jasinski BS, MBA CEO & Director 1957
Ms. Miri Pariente VP of Operations, Regulatory & Quality 1977
Ms. Jeannine Lynch VP of Market Access & Strategy 1965
Mr. David Hexner VP of R&D NA
Mr. Michael A. Lawless Chief Financial Officer & Principal Financial Officer NA
Ms. Kathleen O'Donnell VP of Marketing & New Bus. Devel. NA
Ms. Judy Kula VP of Customer Service, HR & Bus. Affairs NA
Mr. Ami Kraft Exec. Advisor to the CEO 1943

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.